Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception for Lynch Syndrome 5R01CA257375-05 Asad Umar, D.V.M., Ph.D.
Sanda, Martin G

Emory University
United States

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sanda, Martin G

Emory University
United States

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D.
Santomasso, Bianca Denise

Sloan-Kettering Inst Can Research
United States

Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN
Santomasso, Bianca Denise

Sloan-Kettering Inst Can Research
United States

Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN
Santos-Reyes, Luis Javier

Comprehensive Cancer Center/ Univ/Pr
United States

Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Santos-Reyes, Luis Javier

Comprehensive Cancer Center/ Univ/Pr
United States

Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Saphner, Thomas J

Aurora Health Care, Inc.
United States

Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H.
Saphner, Thomas J

Aurora Health Care, Inc.
United States

Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H.
Schallenkamp, John M.

Montana Cancer Consortium
United States

Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 3UG1CA189872-11S1 Vanessa A. White, M.P.H.
Schallenkamp, John M.

Montana Cancer Consortium
United States

Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 3UG1CA189872-11S1 Vanessa A. White, M.P.H.
Schaverien, Mark V

University Of Tx Md Anderson Can Ctr
United States

Lymphedema Prevention Through Immediate Lymphatic Reconstruction 5R01CA292908-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials